What Does It Mean That the CDC Is Starting to Test for Coronavirus Antibodies? Here’s What You Need to Know.

Robin Utrecht/AP

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

The Centers for Disease Control and Prevention is now officially testing Americans for coronavirus antibodies. This could be a major step in controlling the virus, as the tests will indicate whether someone has been infected with the coronavirus in the past—even if they were asymptomaticand allow researchers to finally get some insight into just how far infection has spread.

As I wrote in a long story late last week, these “serological tests” work by detecting antibodies in the blood. People are hoping this means they can be used as defacto immunity tests: Though not proven—an important point to stress—it is likely that if someone has recovered from COVID-19, they have some immunity to the virus, at least in the short term. So, crucially, testing for antibodies could also help identify who among us is safe to return to the workforce. As Shane Crotty, a professor in the Center for Infectious Disease and Vaccine Research at La Jolla Institute for Immunology (LJI), told my colleague James West, “Doctors and nurses are being exposed to this all the time. And if you knew you had a group of people who were immune, you might stratify some of the jobs differently in terms of who takes care of the most severe cases or whatnot.”

One other important thing to know about these tests is that they are different from the diagnostic ones taken so far by more than 1 million Americans. Unlike those tests, which can only detect the virus while someone is infected, serological tests can be accurate for a long time. As I reported last week:

Your body likely starts making antibodies against the coronavirus between seven and 21 days after you’re infected, [Vincent] Racaniello, [a professor of microbiology and immunology at the College of Physicians and Surgeons at Columbia University], says. Those initial antibodies typically stick around in your system for about three months, while other antibodies take a little longer to develop and will likely be found in your blood years after you’ve had COVID-19. “Their levels go down gradually,” Racaniello says. “But there will always be a low level in the blood that you can detect for years and years after infection.” Serological tests can detect both types of antibodies.

In addition to being a tool for uncovering the undiagnosed and the likely immune, experts told me some coronavirus antibodies could also play a role in treating people who are sick (for instance, using plasma from survivors) or even preventing COVID-19 in the first place. As I wrote:

While antibody treatment for sick patients will not directly give them immunity to the coronavirus, it’s possible that administering antibody treatments to people before they get sick could prevent illness temporarily. “When you inject the antibodies into your blood, they end up diffusing into all of your tissues, including your lungs. And so they would prevent infection,” Racaniello says. “That’s how a vaccine would work—except the vaccine would have you make your own antibodies.”

This isn’t the same as being immune, because…your body isn’t making its own response to the coronavirus; you’re still using someone else’s. That’s why, to prevent an infection with antibodies, you’d need an injection every month or two, Racaniello says. While this wouldn’t be considered effective long-term preventive care, this sort of treatment could be especially helpful for health care professionals on the front lines. 

The CDC plans to roll out three individual clinical trials focused on antibodies, STAT and the New York Times first reported. The first study, according to STAT, has already begun and will focus on identifying people who have not been diagnosed with COVID-19 in the country’s coronavirus hotspots. In the second study, which the CDC reportedly hopes to start this summer, health officials will test for antibodies in samples taken from people who were never diagnosed across the country, which will give experts an indication of how the coronavirus has spread nationally. The third study will focus on specific populations, like health care workers, to understand how the virus is spreading among those groups.

If you’re curious to read more about serological testing and some of the common antibody treatments in development, check out the rest of my story here.

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate